Pre-earnings brief
Reports
Tue, Oct 27, 2026
Est. EPS
—
Est. revenue
—
Implied move
±6.0%
EPS beat rate
75%
Ventas, Inc. (VTR) is a real estate investment trust (REIT) focused on healthcare properties, including senior housing and medical office buildings. With a market cap of $41 billion, it plays a crucial role in the healthcare real estate sector, which is influenced by demographic trends such as an aging population and increased healthcare spending.
Last quarter
In Q2 2026, Ventas reported an EPS of $0.99, beating estimates by 3.34%. However, the stock experienced a slight decline of 0.43% the following day, indicating mixed market sentiment.
EPS beat streak
1Q
EPS beat rate
75%
Avg EPS surprise
+1.90%
Avg 1-day reaction
+0.67%
Investors are cautiously optimistic about Ventas's upcoming earnings, given its recent EPS beat history. However, the lack of specific guidance may lead to uncertainty.
Bull case
If Ventas continues its trend of beating EPS estimates, it could signal strong operational performance and increased investor confidence.
Bear case
Conversely, any signs of declining occupancy rates or revenue growth could raise concerns about the company's future performance and lead to a negative market reaction.
The print will turn on these.
Q1
What are the current occupancy rates across Ventas's properties?
Occupancy rates are a critical indicator of demand and operational effectiveness, directly impacting revenue.
Q2
How is Ventas managing its costs in the current economic environment?
Cost management will be crucial for maintaining profitability, especially in a potentially challenging market.
—
Est. EPS
—
Est. Rev
—
Impl. Move
±9.4%
Why consensus could be wrong
The Street may be underestimating the impact of rising healthcare demand on Ventas's occupancy rates, which could lead to stronger-than-expected revenue growth.
Supporting evidence
Ventas has a history of beating EPS estimates, suggesting operational resilience.
The options market is pricing a larger move than historical averages, indicating potential for significant volatility.
Recent demographic trends show increasing demand for healthcare facilities, which may not be fully reflected in current estimates.
Key risk
If occupancy rates exceed 90%, it could invalidate bearish sentiment and drive a positive reassessment of the stock.
Pre-commit to what would confirm each case.
The core thesis revolves around Ventas's ability to maintain high occupancy rates and manage costs effectively in a competitive healthcare real estate market.
Bull confirmed if
Occupancy rates above 90% would confirm strong demand and operational success.
Bear confirmed if
Occupancy rates dropping below 85% would raise significant concerns about future revenue.
What the market is pricing for the move.
Implied Move
±5.96%
Historical Avg
±1.0%
The options market is pricing in a significant move of nearly 6%, suggesting that investors expect volatility around the earnings report.
Options are pricing ±6.0% while VTR has averaged ±1.0% over the last 8 prints — setup is pricing rich.
ATM IV
0.3%
30d HV
15.6%
Smart-money positioning from the most recent 13F filings.
Institutional
105.22%
of float
Insider
0.51%
of float
Holders
1,396
institutions
Top Holders· as of Jun 2026
Blackrock Inc.
55,781,968 sh · $4.5B
10.87%
-1.4%
Likely market behavior by outcome. Not investment advice.
Beat & raise
If Ventas beats expectations, history suggests the stock could rise by about 0.56%, confirming strong operational performance.
In line / cautious
If results are in line with expectations but management is cautious, the stock may see muted movement as investors reassess future growth.
Miss
A miss could lead to a decline of approximately 0.99%, reflecting investor disappointment and concerns about the company's outlook.
The lines on the call that would change the story.
JPMORGAN CHASE & CO
43,693,905 sh · $3.5B
8.52%
23.5%
Vanguard Portfolio Management LLC
42,627,293 sh · $3.4B
8.31%
3.3%
Vanguard Capital Management LLC
31,759,575 sh · $2.5B
6.19%
2.9%
State Street Corporation
30,526,195 sh · $2.4B
5.95%
2.4%
13F filings updated quarterly. Position deltas show change in shares vs. the prior quarter.